In the published article, there was an error in Table 3 as published. During the plotting of this table, there were incorrect correspondences between the headings of the CI, GRS and GCS columns and the contents below. The contents of the CI column were the GRS values, the contents of the GRS column were the GCS values, and the contents of the GCS column were the CI values. The correspondences between the data in these three columns and the column headings are realigned. The corrected Table 3 and its caption appear below.
Table 3
| Case no. and time |
Sex/age (Y) | LVEF (%) | EDVI (ml/m2) | ESVI (ml/m2) | CI (L/min/m2) | GRS (%) | GCS (%) | GLS (%) | |
|---|---|---|---|---|---|---|---|---|---|
| Ⅱ-2 | 2017 | F/44 | 60.43 | 78.33 | 31.00 | 2.98 | 27.16 | −16.7 | −19.35 |
| 2019 | F/46 | 49.89 | 75.94 | 38.05 | 2.23 | 22.65 | −14.9 | −11.18 | |
| Ⅱ-3 | 2017 | F/41 | 51.02 | 101.06 | 49.49 | 2.84 | 24.76 | −15.9 | −15.59 |
| Ⅲ-1 | 2017 | M/20 | 34.23 | 110.62 | 72.75 | 1.90 | 9.63 | −7.03 | −4.52 |
| 2019 | M/22 | 8.03 | 127.57 | 117.33 | 0.72 | 3.84 | −3.3 | −2.31 | |
| Ⅲ-2 | 2017 | F/15 | 65.63 | 76.51 | 26.30 | 3.21 | 34.58 | −19.9 | −15.89 |
| Ⅲ-4 | 2017 | F/23 | 60.92 | 76.61 | 29.94 | 3.08 | 27.46 | −16.6 | −11.98 |
| Ⅲ-5 | 2017 | F/14 | 57.67 | 69.57 | 29.45 | 2.73 | 30.56 | −18.4 | −13.63 |
| Ⅲ-6 | 2017 | M/14 | 54.12 | 89.73 | 41.17 | 3.37 | 21.08 | −12.2 | −10.88 |
| 2019 | M/16 | 45.15 | 130.29 | 71.46 | 3.39 | 10.97 | −7.69 | −4.95 | |
| 2021 | M/18 | 24.37 | 139.40 | 105.42 | 2.45 | 8.24 | −6.64 | −3.45 | |
| 2022 | M/19 | 18.65 | 162.38 | 132.10 | 1.97 | 6.68 | −5.33 | −2.71 | |
Function and strains of LV on CMR and their evolutions during follow-up.
F, female; M, male; LVEF, left ventricle ejection fraction; EDVI, end-diastolic volume index; ESVI, end-systolic volume indexed; CI, cardiac index; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
Danon disease, glycogen storage disease, LAMP2, cardiovascular magnetic resonance, late gadolinium enhancement, feature tracking
Citation
Liu X, Zhai N, Wang X, Wang J, Jiang M, Sun Z, Chen Y, Xu J, Cui Y and Li L (2024) Corrigendum: Cardiovascular magnetic resonance findings in Danon disease: a case series of a family. Front. Cardiovasc. Med. 11:1405171. doi: 10.3389/fcvm.2024.1405171
Received
22 March 2024
Accepted
17 April 2024
Published
29 April 2024
Volume
11 - 2024
Edited and reviewed by
Xiaoyue Zhou, Siemens Healthineers Ltd., China
Updates
Copyright
© 2024 Liu, Zhai, Wang, Wang, Jiang, Sun, Chen, Xu, Cui and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yinghua Cui jyfycyh163.com Lu Li xiajisiyu@163.com
†These authors have contributed equally to this work and share first authorship
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.